Martin S Weber

Summary

Affiliation: Klinikum rechts der Isar
Country: Germany

Publications

  1. ncbi Current treatment strategies for multiple sclerosis - efficacy versus neurological adverse effects
    Martin S Weber
    Department of Neurology, Technische Universitat Munchen, Munich, Germany
    Curr Pharm Des 18:209-19. 2012
  2. ncbi Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease
    Martin S Weber
    Department of Neurology, Technische Universitat Munchen, Munich, Germany
    PLoS ONE 5:e16009. 2010
  3. ncbi Favourable response to plasma exchange in tumefactive CNS demyelination with delayed B-cell response
    Christian L Seifert
    Department of Neurology, Klinikum rechts der Isar, Technische Universitat Munchen, Munchen, Germany
    Mult Scler 18:1045-9. 2012
  4. ncbi The combination of interferon-beta and HMG-CoA reductase inhibition in multiple sclerosis: enthusiasm lost too soon?
    Johann Sellner
    Department of Neurology, Klinikum rechts der Isar, Technische Universitat Munchen, Munchen, Germany
    CNS Neurosci Ther 16:362-73. 2010
  5. ncbi Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
    Klaus Lehmann-Horn
    Department of Neurology, Technische Universitat Munchen, Munich, Germany
    J Neuroinflammation 8:146. 2011
  6. ncbi CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation
    Markus C Kowarik
    Department of Neurology, Klinikum rechts der Isar, Technische Universitat Munchen, 81675 Munich, Germany
    J Neuroinflammation 9:93. 2012
  7. ncbi Disease-modifying agents for multiple sclerosis: recent advances and future prospects
    Til Menge
    Department of Neurology, Heinrich Heine University, Dusseldorf, Germany
    Drugs 68:2445-68. 2008
  8. ncbi The role of antibodies in multiple sclerosis
    Martin S Weber
    Department of Neurology, Technische Universität Müchen, Munich, Germany
    Biochim Biophys Acta 1812:239-45. 2011
  9. ncbi Cooperation of B cells and T cells in the pathogenesis of multiple sclerosis
    Martin S Weber
    Department of Neurology, Technische Universitat Munchen, Ismaningerstrasse 22, 81675, Munich, Germany
    Results Probl Cell Differ 51:115-26. 2010
  10. ncbi The value of the serum neurofilament protein heavy chain as a biomarker for peri-operative brain injury after carotid endarterectomy
    Johann Sellner
    Department of Neurology, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Neurochem Res 34:1969-74. 2009

Collaborators

Detail Information

Publications10

  1. ncbi Current treatment strategies for multiple sclerosis - efficacy versus neurological adverse effects
    Martin S Weber
    Department of Neurology, Technische Universitat Munchen, Munich, Germany
    Curr Pharm Des 18:209-19. 2012
    ..In this review, we aim to critically evaluate the risk/benefit ratio of therapeutic strategies in treatment of MS with a specific focus on infectious neurological side effects...
  2. ncbi Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease
    Martin S Weber
    Department of Neurology, Technische Universitat Munchen, Munich, Germany
    PLoS ONE 5:e16009. 2010
    ..Besides its therapeutic implication, this finding suggests that encounter of the immune system with microbial products may not only be part of CNS autoimmune disease pathogenesis but also of its regulation...
  3. ncbi Favourable response to plasma exchange in tumefactive CNS demyelination with delayed B-cell response
    Christian L Seifert
    Department of Neurology, Klinikum rechts der Isar, Technische Universitat Munchen, Munchen, Germany
    Mult Scler 18:1045-9. 2012
    ..This delay in the development of a humoral immune response may reflect the step-wise B-cell colonization of the CNS and represent an attractive therapeutic window of opportunity...
  4. ncbi The combination of interferon-beta and HMG-CoA reductase inhibition in multiple sclerosis: enthusiasm lost too soon?
    Johann Sellner
    Department of Neurology, Klinikum rechts der Isar, Technische Universitat Munchen, Munchen, Germany
    CNS Neurosci Ther 16:362-73. 2010
    ..Moreover, we try to address the evident question whether usage of this combination routinely requires caution, since the number of IFN-β-treated MS patients receiving statins for lowering of cholesterol is expected to grow...
  5. ncbi Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
    Klaus Lehmann-Horn
    Department of Neurology, Technische Universitat Munchen, Munich, Germany
    J Neuroinflammation 8:146. 2011
    ..We elucidated the regulatory role of un-activated B-cells in EAE and investigated whether anti-CD20 may collaterally diminish regulatory B-cell properties in treatment of neuroimmunological disorders...
  6. ncbi CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation
    Markus C Kowarik
    Department of Neurology, Klinikum rechts der Isar, Technische Universitat Munchen, 81675 Munich, Germany
    J Neuroinflammation 9:93. 2012
    ....
  7. ncbi Disease-modifying agents for multiple sclerosis: recent advances and future prospects
    Til Menge
    Department of Neurology, Heinrich Heine University, Dusseldorf, Germany
    Drugs 68:2445-68. 2008
    ..Finally, with the advent of these highly potent novel therapies, rare, but potentially serious adverse effects have been noted, namely infections and malignancies. These are critically reviewed and put into perspective...
  8. ncbi The role of antibodies in multiple sclerosis
    Martin S Weber
    Department of Neurology, Technische Universität Müchen, Munich, Germany
    Biochim Biophys Acta 1812:239-45. 2011
    ....
  9. ncbi Cooperation of B cells and T cells in the pathogenesis of multiple sclerosis
    Martin S Weber
    Department of Neurology, Technische Universitat Munchen, Ismaningerstrasse 22, 81675, Munich, Germany
    Results Probl Cell Differ 51:115-26. 2010
    ..Taken together, B cells and T cells thus closely support one another to participate in the pathogenesis of MS in an inflammatory but also in a regulatory manner...
  10. ncbi The value of the serum neurofilament protein heavy chain as a biomarker for peri-operative brain injury after carotid endarterectomy
    Johann Sellner
    Department of Neurology, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Neurochem Res 34:1969-74. 2009
    ....